Workflow
Emeren(SOL)
icon
Search documents
Emeren(SOL) - 2024 Q3 - Earnings Call Transcript
2024-11-15 00:19
Emeren Group Ltd (NYSE:SOL) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Gary Dvorchak - Managing Director, The Blueshirt Group Yumin Liu - CEO Ke Chen - CFO Conference Call Participants Philip Shen - Roth Capital Partners Operator Hello, ladies and gentlemen. Welcome and thank you for standing by, for Emeren Group Limited Third Quarter 2024 Earnings Conference Call. Please note that we are recording today's conference call. [Operator Instructions] I will now turn over ...
Emeren(SOL) - 2024 Q3 - Quarterly Report
2024-11-14 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33911 EMEREN GROUP LTD (Exact Name of Registrant as Specified in Its Charter) British Virgin Islands N/A (State or Ot ...
Emeren Announces Third Quarter 2024 Financial Results
Prnewswire· 2024-11-14 21:01
NORWALK, Conn., Nov. 14, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced its unaudited financial results for the third quarter ended September 30, 2024. Emeren's third quarter 2024 financial results and management commentary can be found by accessing the Company's shareholder letter on the quarterly results page of the Investor Relations section of Emeren Group Ltd's website at http ...
Emeren Group: Guidance Appears Out Of Reach, But Potential For A Turning Point
Seeking Alpha· 2024-11-06 17:00
Private investors and former financial advisor specializing in researching growth companies. Articles published will cover both American and European companies up to a maximum capitalization of $15B and will be done with a fundamental analysis focus. The page is intended to focus on small companies with high growth and innovation capabilities. The core focus of articles will be on renewable energy and cutting-edge industrial innovation. Open to all forms of discussion, please click like and comment my artic ...
Emeren Group and Arpinge Partner to Develop 300 MW Battery Storage Portfolio in Italy
Prnewswire· 2024-11-05 11:00
NORWALK, Conn., Nov. 5, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced a co-development agreement with Arpinge, a permanent capital vehicle focused on sustainable infrastructure in Italy, to jointly develop a 300 MW Battery Energy Storage System (BESS) portfolio in Southern Italy. This partnership strengthens Emeren's growing presence in Italy's BESS market, where the Company has a ...
Emeren to Release Third Quarter 2024 Financial Results on November 14, 2024
Prnewswire· 2024-10-24 10:00
NORWALK, Conn., Oct. 24, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024 after the U.S. stock market close on Thursday, November 14, 2024. The Company will hold a conference call to discuss the financial results at 4:30 p.m. U.S. Eastern Time on Thursday, November 14, 2024. What: Emere ...
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD
GlobeNewswire News Room· 2024-10-15 11:30
SOL-1 is now expected to be enrolled and fully randomized by year-end 2024 Topline clinical data from SOL-1 are now expected in Q4 2025 BEDFORD, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced accelerated timelines for the SOL-1 Phase 3 registr ...
Emeren Group (SOL) Stock Dips Amid Solar Sector Volatility
Gurufocus· 2024-10-07 19:31
Emeren Group Ltd (SOL, Financial) experienced a significant share price drop of 5.05%, bringing the stock down to $2.73 per share. During this period, the trading volume reached 256,430 shares, with a turnover rate of 0.50% and a price volatility of 9.23%. The latest financial results for the company reported a revenue of $30.06 million, a net profit of $392,000, and an earnings per share (EPS) of $0.01. The gross profit stood at $9.38 million, with a price-to-earnings (P/E) ratio of -8.84. Among the three ...
Emeren Group Divests a 57 MWp Solar Project Portfolio in France
ZACKS· 2024-10-01 14:16
Emeren Group Ltd. (SOL) recently declared the sale of a 57 megawatt-peak (MWp) solar portfolio of five projects to Trina Solar (France) Systems. This project sale can be expected to boost SOL's revenues in the third quarter of 2024. The five projects include one early-stage, one late-stage and three mid-stage projects. There is a possibility of attaching Battery Energy Storage Systems ("BESS") to this portfolio, which, if attached, will enhance the portfolio's overall value, boosting SOL's revenue prospects ...
This Cryptocurrency Could Be a Major Player by 2030
The Motley Fool· 2024-09-30 12:42
Solana is currently making a run at Ethereum. Bitcoin could be next.Bitcoin (BTC -2.41%) continues to reign as the world's top cryptocurrency, and it's not close. With a massive market cap of $1.3 trillion, Bitcoin is nearly four times larger than its next closest rival, Ethereum (ETH -0.49%). In fact, Bitcoin now accounts for a whopping 57% of the market cap of the entire crypto market.But a number of challengers are gaining on it, and the one that has the most upside potential over the next five years is ...